Literature DB >> 27340018

Rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation (ROHHAD syndrome): A case report and literature review.

S Ibáñez-Micó1, A M Marcos Oltra2, S de Murcia Lemauviel3, R Ruiz Pruneda4, C Martínez Ferrández5, R Domingo Jiménez6.   

Abstract

INTRODUCTION: ROHHAD syndrome (rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation) is a rare and complex disease, presenting in previously healthy children at the age of 2-4 years. Up to 40% of cases are associated with neural crest tumours. DEVELOPMENT: We present the case of a 2-year-old girl with symptoms of rapidly progressing obesity, who a few months later developed hypothalamic dysfunction with severe electrolyte imbalance, behaviour disorder, hypoventilation, and severe autonomic dysregulation, among other symptoms. Although the pathophysiology of this syndrome remains unclear, an autoimmune hypothesis has been proposed for ROHHAD. Therefore, after obtaining a limited response to intravenous immunoglobulins, we decided to test the response to a high dose cyclophosphamide (low dose was not effective either). Unfortunately our patient experienced many severe complications (among them central pontine myelinolysis, from which the patient recovered, and failure to wean from the ventilator requiring tracheostomy and long term ventilation) that required a prolonged ICU stay. Although her behaviour improved, our patient unfortunately died suddenly at home at the age of 5 due to respiratory pathology.
CONCLUSIONS: ROHHAD syndrome is a rare and little-known disease which requires a multidisciplinary approach because it involves complex symptoms and multiple organ system involvement. Alveolar hypoventilation should be identified early and appropriate treatment should be started promptly for the best possible outcome. Immunomodulatory treatment with immunoglobulins, cyclophosphamide, or rituximab has previously resulted in symptom improvement in some cases. Because of the low incidence of the syndrome, multi-centre studies must be carried out in order to gather more accurate information about ROHHAD pathophysiology and design an appropriate therapeutic approach.
Copyright © 2016 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Autoimmune encephalitis; Disautonomía; Disfunción hipotalámica; Dysautonomia; Encefalitis autoinmune; Hipoventilación; Hypothalamic dysfunction; Hypoventilation; ROHHAD syndrome; Síndrome ROHHAD

Mesh:

Substances:

Year:  2016        PMID: 27340018     DOI: 10.1016/j.nrl.2016.04.008

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  8 in total

Review 1.  Adrenal ganglioneuroma: Prognostic factors (Review).

Authors:  Florica Sandru; Mihai Cristian Dumitrascu; Aida Petca; Mara Carsote; Razvan-Cosmin Petca; Ana Maria Oproiu; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-09-22       Impact factor: 2.751

2.  Thoracic Ganglioneuroma Presenting with Paraneoplastic Cerebellitis and ROHHAD-NET Syndrome.

Authors:  Sarbesh Tiwari; Mufeed Arimbrakkunnan; Taruna Yadav; Varuna Vyas; Kirti K Rathod; Vikarn Vishwajeet
Journal:  Ann Indian Acad Neurol       Date:  2022-02-08       Impact factor: 1.714

3.  Evolution of physiologic and autonomic phenotype in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation over a decade from age at diagnosis.

Authors:  Ilya Khaytin; Tracey M Stewart; Frank A Zelko; Mitsu A L Kee; Jennifer N Osipoff; Susan M Slattery; Debra E Weese-Mayer
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

4.  Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Jaewon Shin; Sol Kim; Heon Yung Gee; Joon Suk Lee; Do Hyeon Cha; John Hoon Rim; Se-Jin Park; Ji Hong Kim; Ahmet Uçar; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

5.  ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison.

Authors:  Sarah F Barclay; Casey M Rand; Lisa Nguyen; Richard J A Wilson; Rachel Wevrick; William T Gibson; N Torben Bech-Hansen; Debra E Weese-Mayer
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

6.  A Case Report of ROHHAD Syndrome in an 8-year-old Iranian Boy.

Authors:  Abolfazl Amjadipour; Lobat Shahkar; Faridreza Hanafi
Journal:  Int J Endocrinol Metab       Date:  2021-05-22

7.  Case Report: COVID-19-Associated ROHHAD-Like Syndrome.

Authors:  Irina N Artamonova; Natalia A Petrova; Natalia A Lyubimova; Natalia Yu Kolbina; Alexander V Bryzzhin; Alexander V Borodin; Tatyana A Levko; Ekaterina A Mamaeva; Tatiana M Pervunina; Elena S Vasichkina; Irina L Nikitina; Anna M Zlotina; Alexander Yu Efimtsev; Mikhail M Kostik
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

8.  ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD.

Authors:  Caleigh Mandel-Brehm; Leslie A Benson; Baouyen Tran; Mark P Gorman; Joseph L DeRisi; Andrew F Kung; Sabrina A Mann; Sara E Vazquez; Hanna Retallack; Hannah A Sample; Kelsey C Zorn; Lillian M Khan; Lauren M Kerr; Patrick L McAlpine; Lichao Zhang; Frank McCarthy; Joshua E Elias; Umakanth Katwa; Christina M Astley; Stuart Tomko; Josep Dalmau; William W Seeley; Samuel J Pleasure; Michael R Wilson
Journal:  Ann Neurol       Date:  2022-05-25       Impact factor: 11.274

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.